Page last updated: 2024-08-24

metazocine and naloxone

metazocine has been researched along with naloxone in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19902 (28.57)18.7374
1990's3 (42.86)18.2507
2000's2 (28.57)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cheney, BV1
Aceto, MD; Coop, A; Harris, LS; May, EL; Metcalf, MD; Traynor, JR; Woods, JH1
Bidlack, JM; Bu, Y; Cohen, DJ; Lou, R; Lu, Q; VanAlstine, MA; Wentland, MP1
Costa, EM; Hoffmann, BB; Loew, GH1
Craft, RM; Dykstra, LA; Hargrove, BK; Jones, SR; Mattox, SR; Negus, SS; Picker, MJ; Powell, KR1
Dykstra, LA; Negus, SS; Picker, MJ1
Baba, Y; Ban, M; Fujimura, H; Hori, M; Imai, E; Iwata, N; Morita, T; Niwa, M; Nozaki, M; Suzuki, Y1

Other Studies

7 other study(ies) available for metazocine and naloxone

ArticleYear
Structure-activity relationships for drugs binding to the agonist and antagonist states of the primary morphine receptor.
    Journal of medicinal chemistry, 1988, Volume: 31, Issue:3

    Topics: Algorithms; Animals; Kinetics; Models, Molecular; Narcotic Antagonists; Narcotics; Protein Conformation; Rats; Receptors, Opioid; Structure-Activity Relationship

1988
The influence of esters and carboxylic acids as the N-substituent of opioids. Part 1: Benzomorphans.
    Bioorganic & medicinal chemistry, 2008, Jan-15, Volume: 16, Issue:2

    Topics: Analgesics, Opioid; Benzomorphans; Carboxylic Acids; Esters; Molecular Structure; Stereoisomerism; Structure-Activity Relationship

2008
Syntheses and opioid receptor binding properties of carboxamido-substituted opioids.
    Bioorganic & medicinal chemistry letters, 2009, Jan-01, Volume: 19, Issue:1

    Topics: Amides; Analgesics, Opioid; Humans; Protein Binding; Receptors, Opioid; Structure-Activity Relationship; Tramadol

2009
Opioid agonists binding and responses in SH-SY5Y cells.
    Life sciences, 1992, Volume: 50, Issue:1

    Topics: Alprostadil; Analgesics; Cyclic AMP; Endorphins; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalins; Fentanyl; GTP Phosphohydrolases; Humans; Meperidine; Morphinans; Naloxone; Narcotics; Oxymorphone; Receptors, Opioid; Receptors, Opioid, mu; Tumor Cells, Cultured

1992
Intermediate efficacy mu opioids: examination of their morphine-like stimulus effects and response rate-decreasing effects in morphine-tolerant rats.
    The Journal of pharmacology and experimental therapeutics, 1992, Volume: 263, Issue:2

    Topics: Animals; Discrimination Learning; Dose-Response Relationship, Drug; Drug Resistance; Food; Male; Morphinans; Morphine; Naloxone; Pentazocine; Rats; Receptors, Opioid, mu

1992
Interactions between the discriminative stimulus effects of mu and kappa opioid agonists in the squirrel monkey.
    The Journal of pharmacology and experimental therapeutics, 1991, Volume: 256, Issue:1

    Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics; Animals; Behavior, Animal; Buprenorphine; Drug Interactions; Fentanyl; Learning; Male; Morphinans; Naloxone; Narcotics; Pentobarbital; Pyrrolidines; Receptors, Opioid; Receptors, Opioid, kappa; Receptors, Opioid, mu; Saimiri

1991
Novel nonnarcotic analgesics with an improved therapeutic ratio. Structure-activity relationships of 8-(methylthio)- and 8-(acylthio)-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocines.
    Journal of medicinal chemistry, 1985, Volume: 28, Issue:11

    Topics: Acylation; Analgesia; Animals; Brain; Chemical Phenomena; Chemistry; Methylation; Mice; Morphinans; Morphine; Naloxone; Oxygen; Phenazocine; Rabbits; Rats; Receptors, Opioid; Structure-Activity Relationship; Sulfur

1985